Alternatives to Prostate Cancer Foundation
Prostate Cancer Foundation is a Biotechnology tool: accelerating breakthroughs in prostate cancer diagnosis and treatment. Here are the 53 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Prostate Cancer Foundation
VizgenNot ratedSpatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.
- CYCystic Fibrosis FoundationNot rated
A leading organization dedicated to curing and treating cystic fibrosis.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Deep Science VenturesNot ratedEmpowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.
SOLVE FSHDNot ratedVenture philanthropy organization accelerating treatments for facioscapulohumeral muscular dystrophy (FSHD).
Moderna2.5 out of 5 (2)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- JUJuno TherapeuticsNot rated
Biotechnology company focused on developing cancer immunotherapies.
BioNTechNot ratedGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
Kite PharmaNot ratedBiotechnology company developing and commercializing cell therapies for cancer treatment.
CRISPR TherapeuticsNot ratedBiotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
Mammoth BiosciencesNot ratedBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Seaport TherapeuticsNot ratedDeveloping novel therapeutics to restore gut lymphatic function.
Pixelgen TechnologiesNot ratedA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
Epicrispr BiotechnologiesNot ratedEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- CRCreate MedicinesNot rated
Developing in vivo immunotherapies for autoimmune diseases and cancer.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
Network BioNot ratedLeveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
Showing the next 20 closest matches. See the rest on the Prostate Cancer Foundation profile.
Sponsored rows are paid and labelled. Advertise on this page
